Biomarkers identified for high-altitude PH

Robyn Kalda
6 days ago
1 min read

This study looked at which proteins and metabolic biomarkers might be associated with the development of high-altitude pulmonary hypertension (PH). Looking at data from China, from rat tissues, and from the UK biobank, the researchers identified four proteins and 11 metabolites and built what they describe as a "robust predictive model" to predict and prevent high-altitude pulmonary hypertension.

Read the Journal of Cardiovascular Development and Disease article

Recent Posts

Smoking delays PAH diagnosis, but not CTEPH

Researchers looked at whether cigarette smoking affected the diagnosis and disease progression of patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension

Environmental triggers may contribute to heritable PAH

This study tried to identify new environmental triggers or genetic causes in heritable pulmonary arterial hypertension. They found several potential genes for further exploration, but they also found

Time to diagnosis matters for patients with PAH

This study identified factors associated with a delayed diagnosis of PAH and found that earlier diagnosis (<6 months) and treatment initiation were associated with significantly improved survival. Mor

Comments